Giulia Lanzolla

9PUBLICATIONS
27CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersObstetrics and gynaecologyMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 27, 2026
Beyond Glycemic Control: Ocular Effects of Glucagon-like Peptide-1 Receptor Agonists.

|Apr 16, 2026
Early familial non-medullary thyroid cancer: differences with late-onset and sporadic forms.

|Feb 02, 2026
Subclinical ocular alterations in Graves' disease: The FUMO score, a new tool to predict Graves' orbitopathy progression.

Giulia Lanzolla, Francesca Saba, Silvia Corrias

|Sep 27, 2025
Reply to Douxfils, J.; Foidart, J.-M. Critical Considerations in the Interpretation of Bone Turnover Marker Data in HormonalContraceptive Users. Comment on "Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. Pharmaceuticals 2025, 18, 61".

Alice Tassi, Ambrogio P Londero, Anjeza Xholli

|Mar 27, 2025
Graves' Disease: Is It Time for Targeted Therapy? A Narrative Review.

Nicola Viola, Alessandro Colleo, Mauro Casula

|Feb 13, 2025
Detection of Central Compartment Lymph Node Metastasis of Thyroid Cancer: Usefulness of Intraoperative Thyroglobulin Measurement in Fine Needle Aspiration Washout with and Without Blue Dye Injection.

Chiara Mura, Gian Luigi Canu, Giulia Lanzolla

Pageof 2

Frequent Collaborators

2 joint publications

Francesco Boi

2 joint publications

Alice Tassi

2 joint publications

Ambrogio P Londero

2 joint publications

Anjeza Xholli